Hospital admission and prevalence trends of adult myasthenia gravis in Finland in 2004-2014: A retrospective national registry study

被引:13
作者
Sipila, Jussi O. T. [1 ,2 ,3 ]
Soilu-Hanninen, Merja [2 ,3 ]
Rautava, Paivi [4 ,5 ]
Kyto, Vile [6 ,7 ,8 ,9 ]
机构
[1] North Karelia Cent Hosp, Dept Neurol, Tikkamaentie 16, FI-80210 Joensuu, Finland
[2] Turku Univ Hosp, Div Clin Neurosci, Turku, Finland
[3] Univ Turku, Dept Neurol, Turku, Finland
[4] Univ Turku, Dept Publ Hlth, Turku, Finland
[5] Turku Univ Hosp, Turku Clin Res Ctr, Turku, Finland
[6] Turku Univ Hosp, Heart Ctr, Turku, Finland
[7] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland
[8] Turku Univ Hosp, Ctr Populat Hlth Res, Turku, Finland
[9] Univ Turku, Turku, Finland
关键词
Hospital admission; Hospitalisation; Infection; Myasthenia gravis; Neuroimmunological disease; Treatment; GUILLAIN-BARRE-SYNDROME; MULTIPLE-SCLEROSIS; EPIDEMIOLOGY;
D O I
10.1016/j.jns.2019.116520
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Hospital admission trends in Myasthenia Gravis are largely unknown, so they were here investigated in Finland between 2004 and 2014 using national mandatory registry data. There were 2989 hospital admissions (59.7% for women) for 861 individuals (median 2 admissions/individual) The annual number of admissions (p = .56), the age of admitted patients (p = .24) or length of stay (p = .20) showed no change during the study period. The proportion of infections as the primary diagnosis increased from 4.5% to 10.4% (p = .0056). These admissions lasted longer than admissions with a non-infectious primary diagnosis (median 6 vs. 4 days, p < .0001). In hospital mortality rate was 1.0%, predicted by age over 65 (HR 8.8; p = .0034) and infection as the primary diagnosis (HR 6.9; p < .0001). Annual frequencies of thymectomies (p = .66) or plasmaphereses (p = .12) remained unchanged. Myasthenia drug reimbursement data suggested increasing MG prevalence during the study period (p < .00001). Considering that the annual hospitalisation frequency remained stable, this would suggest decreased need of hospitalisations per patient. The importance of infections as causes of myasthenia hospitalisations merits further study.
引用
收藏
页数:4
相关论文
共 35 条
  • [1] Risk of osteoporotic fractures in multiple sclerosis patients in southwest Finland
    Aivo, J.
    Kurki, S.
    Sumelahti, M. -L.
    Hanninen, K.
    Ruutiainen, J.
    Soilu-Hanninen, M.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2017, 135 (05): : 516 - 521
  • [2] Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries
    Andersen, J. B.
    Heldal, A. T.
    Engeland, A.
    Gilhus, N. E.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2014, 129 : 26 - 31
  • [3] Epidemiology of myasthenia gravis in Ontario, Canada
    Breiner, Ari
    Widdifield, Jessica
    Katzberg, Hans D.
    Barnett, Carolina
    Bril, Vera
    Tu, Karen
    [J]. NEUROMUSCULAR DISORDERS, 2016, 26 (01) : 41 - 46
  • [4] A systematic review of population based epidemiological studies in Myasthenia Gravis
    Carr, Aisling S.
    Cardwell, Chris R.
    McCarron, Peter O.
    McConville, John
    [J]. BMC NEUROLOGY, 2010, 10
  • [5] Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society
    Cetin, Hakan
    Fueloep, Gerhard
    Zach, Heidemarie
    Auff, Eduard
    Zimprich, Fritz
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2012, 124 (21-22) : 763 - 768
  • [6] Early versus later treatment start in multiple sclerosis: a register-based cohort study
    Chalmer, T. A.
    Baggesen, L. M.
    Norgaard, M.
    Koch-Henriksen, N.
    Magyari, M.
    Sorensen, P. S.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (10) : 1262 - E110
  • [7] Treatment strategies for myasthenia gravis: an update
    Diaz-Manera, Jordi
    Rojas Garcia, Ricard
    Illa, Isabel
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (13) : 1873 - 1883
  • [8] Myasthenia Gravis
    Gilhus, Nils E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (26) : 2570 - 2581
  • [9] Myasthenia gravis and infectious disease
    Gilhus, Nils Erik
    Romi, Fredrik
    Hong, Yu
    Skeie, Geir Olve
    [J]. JOURNAL OF NEUROLOGY, 2018, 265 (06) : 1251 - 1258
  • [10] GOLD R, 2008, THER ADV NEUROL DISO, V1, P99, DOI DOI 10.1177/1756285608093888